We understand some people may be hesitant to try a suppository
In fertility and early embryonic development studies, male and female rats were administered twice weekly subcutaneous doses of 0.5, 1.5, or 3 mg/kg (0.3-, 1-, and 2-fold and 0.3-, 0.9-, and 2-fold, respectively, the MRHD of 15 mg once weekly based on AUC)
The standard KLOW dosage is 3.2 mg (10 units) per injection: daily during the activation phase in weeks 14, 5x per week during the remodeling phase in weeks 58, and 2-3x per week during maintenance in weeks 912
They help determine the practical implications of BPC-157 treatment
Nilsson, B
Having long-term constipation may increase your risk of bowel obstruction